What is keratoconus? [pronounced KEHR-uh-toh-KOH-nus]
Keratoconus is an eye condition in which the regularly dome-shaped cornea (the clear front window of the eye) bulges outwards and thins over time. Symptoms are typically first noticed in the late teens or early 20’s and tend to progress slowly over the next 10 to 20 years. Keratoconus occurs in approximately 1 in 2000 people and is usually present in both eyes.
What causes keratoconus?
Little is known about what causes keratoconus. A gradual weakening of corneal tissue is thought to lead to the condition. About 10% of people with keratoconus have a family history of the condition. Vigorous and prolonged eye rubbing has also been associated with keratoconus.
What are the symptoms of keratoconus?
Depending on the rate of progression and severity, keratoconus can have mild to severe effects on your vision. Keratoconus affects everyone differently. In some people keratoconus progresses until surgical treatment is required and in others it stops progressing on its own. One eye is often affected more than the other.
Early symptoms of keratoconus may include:
- Mild blurring and distortion of vision
- Sensitivity to light
- Mild eye irritation
- Eye strain
Symptoms of more advanced keratoconus may include:
- Increased blurring and distortion of vision
- Increased nearsightedness or astigmatism
- Frequent eyeglass prescription changes
- Sensitivity or intolerance to contact lenses
How is keratoconus treated?
Keratoconus sometimes settles down on its own and does not require surgical treatment. Glasses or specially fitted contact lenses may be sufficient to maintain an acceptable level of vision.
Unfortunately, in about 15% of cases, keratoconus has an aggressive course and vision deteriorates to the point that surgical intervention is necessary.
The primary surgical treatment for advanced keratoconus is a corneal transplant which involves replacing the damaged cornea with a healthy donor cornea. Corneal transplants for keratoconus have a very high success rate but have risks of infection or rejection.
Recently, treatments have been developed to treat keratoconus at earlier stages which may be able to prevent or delay the need for corneal transplants
Corneal collagen cross-linking (CXL) is a non-invasive treatment where riboflavin and ultraviolet light are applied to the cornea. CXL strengthens and adds resilience to corneas affected by keratoconus and can help prevent vision from getting worse.
More information about Corneal Cross-linking can be found here
When contact lenses can no longer be tolerated, intrastromal ring segments may represent a less invasive option than corneal transplants to correct nearsightedness and astigmatism.
If you would like to learn more about keratoconus and CXL, please visit the National Keratoconus Foundation www.nkcf.org.